[Double-blind study on 3 antidepressive agents. 2. Clinical comparison of noxiptiline, nor-noxiptiline, and amitryptiline using the AMP system].
D000275:Adjustment Disorders / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D000368:Aged; D000639:Amitriptyline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000704:Analysis of Variance; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy; D003986:Dibenzocycloheptenes / Q000008:administration & dosage / Q000627:therapeutic use*; D004123:Dimethylamines / Q000008:administration & dosage / Q000627:therapeutic use; D004328:Drive / Q000187:drug effects; D005260:Female; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D010091:Oximes / Q000008:administration & dosage / Q000627:therapeutic use; D010468:Perceptual Disorders / Q000188:drug therapy; D012472:Salivation / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D003986:Dibenzocycloheptenes; D004123:Dimethylamines; D010091:Oximes; D000639:Amitriptyline
Doppelblindprüfung von drei Antidepressiva. 2. Klinischer Vergleich von Noxiptilin, Nor-Noxiptilin und Amitriptylin mit dem AMP-System.